Diagnosing Segregation in Pharmaceutical Blends: From NIR Profiles to Formulation Decisions

A pharmaceutical blend can pass uniformity testing yet segregate during manufacturing. Discover how NIR concentration profiles, particle-size measurements, and predictive powder-property indices help formulation scientists identify segregation mechanisms and select effective corrective actions.

FDA’s Proposed Hub-and-Spoke Distributed Manufacturing Rule: What It Means for Blend Uniformity and Granulation Consistency

FDA's proposed hub-and-spoke registration rule treats geographically separate manufacturing units as one establishment. The registration paperwork is new; proving that blend uniformity, granulation endpoints, and moisture behavior actually match between sites is the older, harder problem.

Powder Segregation Test: What a Simple Bottle Method Can and Cannot Show

A bottle test is a fast, qualitative screen for whether [...]

Go to Top